Our Managing Director, Steve Le Feuvre, represented Lysaght at the Pharmaceutical Trade Marks Group conference held in Paris, France on 13 and 14 March.

As well as meeting up with many clients and associates from around the world, it was a good opportunity to have discussions on the latest thoughts about the implications of Brexit for the I.P. industry which certainly is the “hot topic” in Europe at present.

Lysaght is heavily involved with the protection of trade marks, designs and patents for the pharmaceutical industry world-wide, and has been a keen supporter of PTMG since it was founded in 1970.